Skip to content

DEFENSE Trial

DEFENSE Trial - DEFENSE Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000007212
Enrollment
151
Registered
2012-02-02
Start date
2012-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subjects indicated for ICD or CRT-D.

Interventions

None listed

Sponsors

Medtronic Japan Co., Ltd
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: i, ICD or CRT-D patients who receive newly or replace to the device equipped with SST. ii, Patients who understand and sign the informed consent.

Exclusion criteria

Exclusion criteria: i, Patients who cannot visit the hospital according to the follow-up schedule or who cannot collect the data through the CareLink system. ii, Patients who are unwilling to provide written informed consent. iii, Patients who are anticipated not to be able to set the device with required programming iv, Patients who are not expected to survive more than 6 months.

Design outcomes

Primary

MeasureTime frame
ICD shock reduction rate with a new algorithm of Medtronic ICD/CRT-D, SST.

Secondary

MeasureTime frame
ICD shock rate and the cause of inappropriate shocks.

Countries

Japan

Contacts

Public ContactRyusuke Kinoshita, Tomoyuki Yamaguchi

Medtronic Japan Co., Ltd. CRDM

ryusuke.kinoshita@medtronic.com093-512-4666

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026